| Literature DB >> 28406627 |
Thanigaimalai Pillaiyar1, Meryem Köse1, Katharina Sylvester1, Heike Weighardt2, Dominik Thimm1, Gleice Borges1, Irmgard Förster2, Ivar von Kügelgen3, Christa E Müller1.
Abstract
The Gi protein-coupled receptor GPR84, which is activated by (hydroxy)fatty acids, is highly expressed on immune cells. Recently, 3,3'-diindolylmethane was identified as a heterocyclic, nonlipid-like GPR84 agonist. We synthesized a broad range of diindolylmethane derivatives by condensation of indoles with formaldehyde in water under microwave irradiation. The products were evaluated at the human GPR84 in cAMP and β-arrestin assays. Structure-activity relationships (SARs) were steep. 3,3'-Diindolylmethanes bearing small lipophilic residues at the 5- and/or 7-position of the indole rings displayed the highest activity in cAMP assays, the most potent agonists being di(5-fluoro-1H-indole-3-yl)methane (38, PSB-15160, EC50 80.0 nM) and di(5,7-difluoro-1H-indole-3-yl)methane (57, PSB-16671, EC50 41.3 nM). In β-arrestin assays, SARs were different, indicating biased agonism. The new compounds were selective versus related fatty acid receptors and the arylhydrocarbon receptor. Selected compounds were further investigated and found to display an ago-allosteric mechanism of action and increased stability in comparison to the lead structure.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28406627 DOI: 10.1021/acs.jmedchem.6b01593
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446